Key result
Tracheostomy is associated with comparable 1-year survival in pediatric patients awaiting cardiac transplant.
Why the study?
There was limited evidence on the use of tracheostomy associated with pediatric cardiac transplantation in children unable to wean off mechanical ventilation.
Does tracheostomy affect survival or complications in pediatric patients listed for cardiac transplantation?
Cohort (n=211)
No
Does tracheostomy affect survival or complications in pediatric patients listed for cardiac transplantation?
Answers are grounded in this paper and cite their sources.
Tracheostomy is a safe short-term measure for pediatric patients awaiting cardiac transplantation who require prolonged mechanical ventilation, with no significant negative impact on 1-year survival.
BACKGROUND: Children with end-stage heart failure listed for cardiac transplantation may require mechanical ventilation and/or circulatory support whilst awaiting transplantation. A subgroup of these patients is unable to wean off mechanical ventilator support and undergo tracheostomy to enhance quality of life and allow de-escalation of intensive care. There is limited evidence of the use of tracheostomy associated with pediatric cardiac transplantation. We describe outcomes to better inform future management of these patients. METHODS: A single-centre, retrospective study was performed, assessing all pediatric patients (< 18 years) listed for cardiac transplant from 2006 to 2017. We assessed background demographics and outcomes, including cardiac diagnosis, complications, insertion of ventricular assist device and survival. We identified patients who underwent tracheostomy after listing and compared this group with non-tracheostomised patients. RESULTS: Two hundred and eleven patients were listed for cardiac transplant, of whom 44 (21%) underwent tracheostomy after listing. The main indication for tracheostomy was failure to wean from mechanical ventilation (36%). Complications after tracheostomy included localized infection, granuloma, obstruction and hemorrhage, but were generally minor. Median time for tracheostomy decannulation was 75 days. When comparing tracheostomy versus non-tracheostomy patients, there were no significant differences in age, weight or time to transplant. Survival was comparable between the non-tracheostomy and tracheostomy groups at 1-year, 97% versus 94% respectively. CONCLUSION: There is no evidence from our study that patients awaiting cardiac transplant who undergo tracheostomy have significant complications or reduced survival. Tracheostomy is usually a short-term measure and should be considered in the management of children receiving prolonged ventilation around the time of cardiac transplantation.
No takes yet. Share an insight, caveat, or question.
Day et al. (2025) conducted a cohort in End-stage heart failure listed for cardiac transplantation (n=211). Tracheostomy vs. Non-tracheostomised patients was evaluated on 1-year survival. In pediatric patients awaiting cardiac transplant, 1-year survival was comparable between those who underwent tracheostomy and those who did not.
Synapse has enriched 10 related papers. Consider them for comparative context: